Bewitched, bothered, and bewildered
Consumers view the new drug benefit with caution, concern, and some optimism
At a glance
In this consumer survey, four out of 10 respondents reported that they either had signed up for a Medicare drug plan (33.5%) or planned to enroll in one (5.4%). Another 21.2% had not decided yet, claiming they needed more information before making a decision, while another 39.9% said they did not plan to sign up for a drug plan.
Some felt they had no choice when it came to deciding whether they would participate in Medicare Part D. "I had to because I was enrolled in Medicaid," noted one person. "They said if I didn't [join Part D], I would be fined," explained another. "I decided to sign up for something that I did not understand and did not know where to go for help," said another respondent. There was also this poi-gnant explanation: "I had nothing; now I have something."
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
